Literature DB >> 11430403

Contribution of multidrug efflux pumps to multiple antibiotic resistance in veterinary clinical isolates of Pseudomonas aeruginosa.

K L Beinlich1, R Chuanchuen, H P Schweizer.   

Abstract

The contribution of efflux pumps to multidrug resistance in 12 Pseudomonas aeruginosa isolates from various animal sources was assessed. Western immunoblot analyses demonstrated that all twelve isolates expressed significant levels of the MexAB OprM efflux system whereas two isolates simultaneously expressed the MexEF OprN or MexXY systems, respectively. One strain contained a single mutation in mexR, a regulator of mexAB-oprM expression, that did not adversely affect the MexR amino acid sequence, and three isolates contained the same, single base change in the mexA-mexR intergenic region. The MexXY-expressing strain contained two base substitutions in its mexZ regulatory gene which did not alter the MexR sequence.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11430403     DOI: 10.1111/j.1574-6968.2001.tb10631.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  15 in total

Review 1.  The TetR family of transcriptional repressors.

Authors:  Juan L Ramos; Manuel Martínez-Bueno; Antonio J Molina-Henares; Wilson Terán; Kazuya Watanabe; Xiaodong Zhang; María Trinidad Gallegos; Richard Brennan; Raquel Tobes
Journal:  Microbiol Mol Biol Rev       Date:  2005-06       Impact factor: 11.056

2.  Role of the AcrAB-TolC efflux pump in determining susceptibility of Haemophilus influenzae to the novel peptide deformylase inhibitor LBM415.

Authors:  Charles R Dean; Shubha Narayan; Denis M Daigle; JoAnn L Dzink-Fox; Xiaoling Puyang; Kathryn R Bracken; Karl E Dean; Beat Weidmann; Zhengyu Yuan; Rakesh Jain; Neil S Ryder
Journal:  Antimicrob Agents Chemother       Date:  2005-08       Impact factor: 5.191

3.  Hypoxia increases antibiotic resistance in Pseudomonas aeruginosa through altering the composition of multidrug efflux pumps.

Authors:  Bettina Schaible; Cormac T Taylor; Kirsten Schaffer
Journal:  Antimicrob Agents Chemother       Date:  2012-01-30       Impact factor: 5.191

4.  Efflux-mediated resistance to tigecycline (GAR-936) in Pseudomonas aeruginosa PAO1.

Authors:  Charles R Dean; Melissa A Visalli; Steven J Projan; Phaik-Eng Sum; Patricia A Bradford
Journal:  Antimicrob Agents Chemother       Date:  2003-03       Impact factor: 5.191

Review 5.  Efflux-mediated drug resistance in bacteria.

Authors:  Xian-Zhi Li; Hiroshi Nikaido
Journal:  Drugs       Date:  2004       Impact factor: 9.546

6.  Enhancement of the mexAB-oprM efflux pump expression by a quorum-sensing autoinducer and its cancellation by a regulator, MexT, of the mexEF-oprN efflux pump operon in Pseudomonas aeruginosa.

Authors:  Hideaki Maseda; Isao Sawada; Kohjiro Saito; Hiroo Uchiyama; Taiji Nakae; Nobuhiko Nomura
Journal:  Antimicrob Agents Chemother       Date:  2004-04       Impact factor: 5.191

7.  The MexJK efflux pump of Pseudomonas aeruginosa requires OprM for antibiotic efflux but not for efflux of triclosan.

Authors:  Rungtip Chuanchuen; Craig T Narasaki; Herbert P Schweizer
Journal:  J Bacteriol       Date:  2002-09       Impact factor: 3.490

8.  Aminoglycoside resistance of Pseudomonas aeruginosa in cystic fibrosis results from convergent evolution in the mexZ gene.

Authors:  Michelle H Prickett; Alan R Hauser; Susanna A McColley; Joanne Cullina; Eileen Potter; Cathy Powers; Manu Jain
Journal:  Thorax       Date:  2016-06-20       Impact factor: 9.139

9.  Evidence of MexT-independent overexpression of MexEF-OprN multidrug efflux pump of Pseudomonas aeruginosa in presence of metabolic stress.

Authors:  Ayush Kumar; Herbert P Schweizer
Journal:  PLoS One       Date:  2011-10-24       Impact factor: 3.240

Review 10.  Triclosan: current status, occurrence, environmental risks and bioaccumulation potential.

Authors:  Gurpreet Singh Dhillon; Surinder Kaur; Rama Pulicharla; Satinder Kaur Brar; Maximiliano Cledón; Mausam Verma; Rao Y Surampalli
Journal:  Int J Environ Res Public Health       Date:  2015-05-22       Impact factor: 3.390

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.